icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
June 21-24 2023 		Back grey_arrow_rt.gif
 
 
 
Denifanstat, a fatty acid synthase (FASN) inhibitor for the
treatment of biopsy-proven NASH: A 26-week interim analysis
of the FASCINATE-2 Phase 2b trial
 
 
  EASL June 21-24 Vienna NAFLD Therapy

0628231

0628232

0628233

0628234

0628235

0628236

0628237

0628238

0628239